1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:70832 6480464 o, p'-DDT affects the expression of CYP51 mRNA CTD PMID:18925944 1,1-dichloroethene decreases expression ISO RGD:70832 6480464 vinylidene chloride results in decreased expression of CYP51 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:70832 6480464 ethylene dichloride results in decreased expression of CYP51 mRNA CTD PMID:28189721 , PMID:28960355 1-(3-(trifluoromethyl)phenyl)piperazine increases expression EXP 6480464 1-(3-trifluoromethylphenyl)piperazine results in increased expression of CYP51 mRNA CTD PMID:26821219 1-benzylpiperazine increases expression EXP 6480464 N-benzylpiperazine results in increased expression of CYP51 mRNA CTD PMID:26821219 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYP51 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of CYP51 mRNA CTD PMID:17351261 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYP51 mRNA CTD PMID:17108234 17beta-estradiol increases expression ISO RGD:1345262 6480464 Estradiol results in increased expression of CYP51A1 mRNA CTD PMID:19167446 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:70832 6480464 Dihydrotestosterone results in decreased expression of CYP51 mRNA CTD PMID:29367455 1H-pyrazole increases expression ISO RGD:70832 6480464 pyrazole results in increased expression of CYP51 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:70832 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 , PMID:30722647 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1345262 6480464 2 more ... CTD PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP51 mRNA CTD PMID:26232522 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:70832 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP51 mRNA CTD PMID:28213091 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:70832 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28213091 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP51 mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CYP51 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CYP51 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:70832 6480464 Glucosamine results in increased expression of CYP51 mRNA CTD PMID:17178593 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one multiple interactions ISO RGD:1345262 6480464 CYP51A1 gene inhibits the reaction [Itraconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases activity ISO RGD:1345262 6480464 Itraconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases response to substance ISO RGD:1345262 6480464 CYP51A1 gene results in decreased susceptibility to Itraconazole CTD PMID:18694951 2-hydroxypropanoic acid increases expression ISO RGD:1345262 6480464 Lactic Acid results in increased expression of CYP51A1 mRNA CTD PMID:30851411 24,25-dihydrolanosterol decreases abundance ISO RGD:1345262 6480464 CYP51A1 mRNA results in decreased abundance of lanostenol CTD PMID:23125191 3',5'-cyclic AMP increases expression ISO RGD:70832 6480464 Cyclic AMP results in increased expression of CYP51 mRNA CTD PMID:25576683 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1345262 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CYP51A1 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of CYP51 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:70832 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CYP51 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1345262 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CYP51A1 mRNA CTD PMID:28628672 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile decreases activity ISO RGD:1345262 6480464 Fadrozole results in decreased activity of CYP51A1 protein CTD PMID:16989930 4-hydroxyphenyl retinamide decreases expression ISO RGD:70832 6480464 Fenretinide results in decreased expression of CYP51A1 mRNA CTD PMID:28973697 5-fluorouracil affects response to substance ISO RGD:1345262 6480464 CYP51A1 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP51 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO RGD:1345262 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP51A1 mRNA CTD PMID:22079614 8-Br-cAMP multiple interactions ISO RGD:70832 6480464 [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA more ... CTD PMID:18467523 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYP51 mRNA CTD PMID:31881176 acetohydrazide increases expression ISO RGD:70832 6480464 acetylhydrazine results in increased expression of CYP51 mRNA CTD PMID:15282401 aflatoxin B1 decreases expression ISO RGD:70832 6480464 Aflatoxin B1 results in decreased expression of CYP51 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO RGD:1345262 6480464 Aflatoxin B1 results in decreased expression of CYP51A1 mRNA CTD PMID:27153756 aldehydo-D-glucosamine increases expression ISO RGD:70832 6480464 Glucosamine results in increased expression of CYP51 mRNA CTD PMID:17178593 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of CYP51 mRNA CTD PMID:17785943 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP51 mRNA CTD PMID:16483693 arsane affects methylation ISO RGD:1345262 6480464 Arsenic affects the methylation of CYP51A1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1345262 6480464 Arsenic affects the methylation of CYP51A1 gene CTD PMID:25304211 benzalkonium chloride increases expression ISO RGD:70832 6480464 Benzalkonium Compounds results in increased expression of CYP51 mRNA CTD PMID:31199489 benzo[a]pyrene increases expression ISO RGD:70832 6480464 Benzo(a)pyrene results in increased expression of CYP51A1 mRNA CTD PMID:20127859 benzo[a]pyrene decreases expression ISO RGD:1345262 6480464 Benzo(a)pyrene results in decreased expression of CYP51A1 mRNA CTD PMID:21632981 , PMID:26238291 benzo[a]pyrene decreases expression ISO RGD:70832 6480464 Benzo(a)pyrene results in decreased expression of CYP51 mRNA CTD PMID:19770486 , PMID:22228805 beta-D-glucosamine increases expression ISO RGD:70832 6480464 Glucosamine results in increased expression of CYP51 mRNA CTD PMID:17178593 beta-naphthoflavone multiple interactions ISO RGD:70832 6480464 AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYP51 mRNA] CTD PMID:22234961 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP51 mRNA CTD PMID:18164116 beta-naphthoflavone decreases expression ISO RGD:1345262 6480464 beta-Naphthoflavone results in decreased expression of CYP51 mRNA CTD PMID:22234961 beta-naphthoflavone decreases expression ISO RGD:70832 6480464 beta-Naphthoflavone results in decreased expression of CYP51 mRNA CTD PMID:22234961 bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of CYP51 mRNA CTD PMID:17719200 bifonazole decreases activity ISO RGD:1345262 6480464 bifonazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:70832 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 more ... bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of CYP51 mRNA CTD PMID:26472102 bis(2-ethylhexyl) phthalate increases expression ISO RGD:70832 6480464 Diethylhexyl Phthalate results in increased expression of CYP51 mRNA CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP51 mRNA, bisphenol A results in increased expression of CYP51A1 mRNA CTD PMID:12075121 , PMID:25181051 bisphenol A affects expression ISO RGD:70832 6480464 bisphenol A affects the expression of CYP51 mRNA CTD PMID:30566610 bisphenol A increases expression ISO RGD:1345262 6480464 bisphenol A results in increased expression of CYP51A1 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:70832 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 , PMID:30722647 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP51 mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:70832 6480464 bisphenol A results in increased expression of CYP51 mRNA CTD PMID:25270620 bisphenol F increases expression ISO RGD:70832 6480464 4, 4'-bisphenol F results in increased expression of CYP51 mRNA CTD PMID:25576683 bitertanol decreases activity ISO RGD:1345262 6480464 bitertanol results in decreased activity of CYP51A1 protein CTD PMID:16989930 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of CYP51 mRNA CTD PMID:12628495 Butylbenzyl phthalate decreases expression EXP 6480464 butylbenzyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:26472102 carbon nanotube increases expression ISO RGD:70832 6480464 Nanotubes, Carbon analog results in increased expression of CYP51 mRNA, Nanotubes, Carbon results in increased expression of CYP51 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1345262 6480464 Nanotubes, Carbon results in decreased expression of CYP51A1 mRNA CTD PMID:28673683 carbon nanotube decreases expression ISO RGD:70832 6480464 Nanotubes, Carbon analog results in decreased expression of CYP51 mRNA, Nanotubes, Carbon results in decreased expression of CYP51 mRNA CTD PMID:25620056 cerium trichloride affects expression ISO RGD:70832 6480464 cerous chloride affects the expression of CYP51 mRNA CTD PMID:23139204 chloroprene decreases expression ISO RGD:70832 6480464 Chloroprene results in decreased expression of CYP51 mRNA CTD PMID:23125180 chromium(6+) affects expression ISO RGD:70832 6480464 chromium hexavalent ion affects the expression of CYP51 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:70832 6480464 Ciguatoxins affects the expression of CYP51 mRNA CTD PMID:18353800 cisplatin affects expression ISO RGD:1345262 6480464 Cisplatin affects the expression of CYP51A1 mRNA CTD PMID:27594783 clobetasol increases expression ISO RGD:70832 6480464 Clobetasol results in increased expression of CYP51 mRNA CTD PMID:27462272 clotrimazole decreases activity ISO RGD:1345262 6480464 Clotrimazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 clotrimazole decreases response to substance ISO RGD:1345262 6480464 CYP51A1 gene results in decreased susceptibility to Clotrimazole CTD PMID:18694951 cobalt dichloride decreases expression ISO RGD:1345262 6480464 cobaltous chloride results in decreased expression of CYP51A1 mRNA CTD PMID:19320972 cocaine decreases expression ISO RGD:1345262 6480464 Cocaine results in decreased expression of CYP51 mRNA CTD PMID:12629581 copper atom decreases expression ISO RGD:70832 6480464 Copper results in decreased expression of CYP51 mRNA CTD PMID:17205981 copper atom decreases expression EXP 6480464 Copper results in decreased expression of CYP51 mRNA CTD PMID:30556269 copper(0) decreases expression ISO RGD:70832 6480464 Copper results in decreased expression of CYP51 mRNA CTD PMID:17205981 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of CYP51 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1345262 6480464 Copper Sulfate results in decreased expression of CYP51A1 mRNA CTD PMID:19549813 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of CYP51 mRNA CTD PMID:18480146 coumestrol increases expression ISO RGD:1345262 6480464 Coumestrol results in increased expression of CYP51A1 mRNA CTD PMID:19167446 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CYP51 mRNA CTD PMID:18172885 cyclosporin A increases expression ISO RGD:1345262 6480464 Cyclosporine results in increased expression of CYP51A1 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1345262 6480464 Cyclosporine results in decreased expression of CYP51A1 mRNA CTD PMID:25562108 cyproconazole affects expression ISO RGD:70832 6480464 cyproconazole affects the expression of CYP51 mRNA CTD PMID:22045034 cyproconazole decreases activity ISO RGD:1345262 6480464 cyproconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 dexamethasone decreases expression ISO RGD:70832 6480464 Dexamethasone results in decreased expression of CYP51 mRNA CTD PMID:17998272 dexamethasone multiple interactions ISO RGD:1345262 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CYP51A1 mRNA CTD PMID:28628672 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of CYP51 mRNA CTD PMID:15102944 dibutyl phthalate increases expression ISO RGD:70832 6480464 Dibutyl Phthalate results in increased expression of CYP51 mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CYP51 mRNA CTD PMID:17379624 more ... dichloromethane affects expression ISO RGD:70832 6480464 Methylene Chloride affects the expression of CYP51 mRNA CTD PMID:28392392 diclofenac increases expression ISO RGD:70832 6480464 Diclofenac results in increased expression of CYP51 mRNA CTD PMID:26934552 diclofenac decreases activity ISO RGD:70832 6480464 Diclofenac metabolite results in decreased activity of CYP51A1 protein CTD PMID:28960974 difenoconazole increases expression EXP 6480464 difenoconazole results in increased expression of CYP51 mRNA CTD PMID:28263823 difenoconazole increases expression ISO RGD:70832 6480464 difenoconazole results in increased expression of CYP51 mRNA CTD PMID:29337257 dioxygen multiple interactions ISO RGD:70832 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP51 mRNA CTD PMID:30529165 dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:26472102 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CYP51 mRNA CTD PMID:21551480 econazole decreases response to substance ISO RGD:1345262 6480464 CYP51A1 gene results in decreased susceptibility to Econazole CTD PMID:18694951 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of CYP51 mRNA CTD PMID:29391264 enilconazole decreases activity ISO RGD:1345262 6480464 enilconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 epoxiconazole decreases activity ISO RGD:1345262 6480464 epoxiconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 ergosterol multiple interactions ISO RGD:1345262 6480464 CYP51A1 gene inhibits the reaction [Fluconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 erlotinib hydrochloride increases response to substance ISO RGD:1345262 6480464 CYP51A1 mRNA results in increased susceptibility to Erlotinib Hydrochloride CTD PMID:23125191 ethanol multiple interactions EXP 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of CYP51 mRNA CTD PMID:17347304 ethanol multiple interactions ISO RGD:70832 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP51 mRNA CTD PMID:30517762 ethanol increases expression ISO RGD:70832 6480464 Ethanol results in increased expression of CYP51 mRNA CTD PMID:19167417 , PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1345262 6480464 Ethyl Methanesulfonate results in decreased expression of CYP51A1 mRNA CTD PMID:23649840 fenarimol increases expression EXP 6480464 fenarimol results in increased expression of CYP51 mRNA CTD PMID:28970091 fenarimol increases expression ISO RGD:70832 6480464 fenarimol results in increased expression of CYP51 mRNA CTD PMID:29337257 fipronil increases expression ISO RGD:1345262 6480464 fipronil results in increased expression of CYP51A1 mRNA CTD PMID:27091632 fluconazole decreases activity ISO RGD:1345262 6480464 Fluconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 fluconazole multiple interactions ISO RGD:1345262 6480464 CYP51A1 gene inhibits the reaction [Fluconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 fluconazole decreases response to substance ISO RGD:1345262 6480464 CYP51A1 gene results in decreased susceptibility to Fluconazole CTD PMID:18694951 fluoranthene decreases expression ISO RGD:70832 6480464 fluoranthene results in decreased expression of CYP51 mRNA CTD PMID:28329830 flusilazole decreases activity ISO RGD:1345262 6480464 flusilazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 flusilazole affects expression ISO RGD:70832 6480464 flusilazole affects the expression of CYP51 mRNA CTD PMID:22634333 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of CYP51 mRNA CTD PMID:22664269 flusilazole increases expression ISO RGD:70832 6480464 flusilazole results in increased expression of CYP51 mRNA CTD PMID:21192963 , PMID:29337257 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP51 mRNA CTD PMID:24136188 formaldehyde decreases expression ISO RGD:1345262 6480464 Formaldehyde results in decreased expression of CYP51A1 mRNA CTD PMID:23649840 furan increases expression ISO RGD:70832 6480464 furan results in increased expression of CYP51 mRNA CTD PMID:24183702 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CYP51 mRNA CTD PMID:17785943 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of CYP51 mRNA CTD PMID:24915197 hexaconazole decreases activity ISO RGD:1345262 6480464 hexaconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 hydrazine increases expression ISO RGD:70832 6480464 hydrazine results in increased expression of CYP51 mRNA CTD PMID:15282401 hydrogen peroxide multiple interactions ISO RGD:1345262 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA CTD PMID:18032389 hydrogen peroxide affects expression ISO RGD:1345262 6480464 Hydrogen Peroxide affects the expression of CYP51A1 mRNA CTD PMID:21179406 indometacin multiple interactions ISO RGD:1345262 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CYP51A1 mRNA CTD PMID:28628672 isotretinoin decreases expression ISO RGD:1345262 6480464 Isotretinoin results in decreased expression of CYP51A1 mRNA CTD PMID:20436886 itraconazole decreases activity ISO RGD:1345262 6480464 Itraconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 itraconazole decreases response to substance ISO RGD:1345262 6480464 CYP51A1 gene results in decreased susceptibility to Itraconazole CTD PMID:18694951 itraconazole multiple interactions ISO RGD:1345262 6480464 CYP51A1 gene inhibits the reaction [Itraconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 ketoconazole decreases activity ISO RGD:1345262 6480464 Ketoconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CYP51 mRNA CTD PMID:28263823 ketoconazole decreases response to substance ISO RGD:1345262 6480464 CYP51A1 gene results in decreased susceptibility to Ketoconazole CTD PMID:18694951 ketoconazole multiple interactions EXP 6480464 [Ketoconazole results in increased activity of CYP51 protein] which results in increased abundance of Lanosterol CTD PMID:12617470 ketoconazole multiple interactions ISO RGD:1345262 6480464 CYP51A1 gene inhibits the reaction [Ketoconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 ketoconazole increases activity EXP 6480464 Ketoconazole results in increased activity of CYP51 protein CTD PMID:12617470 ketoconazole increases expression ISO RGD:70832 6480464 Ketoconazole results in increased expression of CYP51 mRNA, Ketoconazole results in increased expression of CYP51 protein CTD PMID:17966066 , PMID:29337257 lanosterol multiple interactions EXP 6480464 [Ketoconazole results in increased activity of CYP51 protein] which results in increased abundance of Lanosterol CTD PMID:12617470 lanosterol multiple interactions ISO RGD:1345262 6480464 CYP51A1 gene inhibits the reaction [Fluconazole results in decreased metabolism of and results in increased abundance of Lanosterol] more ... CTD PMID:18694951 lead nitrate increases expression ISO RGD:70832 6480464 lead nitrate results in increased expression of CYP51 mRNA CTD PMID:22293356 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of CYP51 mRNA CTD PMID:15475176 lead nitrate multiple interactions ISO RGD:70832 6480464 [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA] CTD PMID:22293356 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CYP51 mRNA CTD PMID:24136188 leflunomide decreases expression ISO RGD:1345262 6480464 leflunomide results in decreased expression of CYP51A1 mRNA CTD PMID:28988120 letrozole decreases activity ISO RGD:1345262 6480464 letrozole results in decreased activity of CYP51A1 protein CTD PMID:16989930 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of CYP51 mRNA CTD PMID:24136188 limonene increases expression EXP 6480464 limonene results in increased expression of CYP51 mRNA CTD PMID:12815608 lithocholic acid decreases expression ISO RGD:70832 6480464 Lithocholic Acid results in decreased expression of CYP51 mRNA CTD PMID:20359477 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CYP51 mRNA CTD PMID:30467583 methyl methanesulfonate decreases expression ISO RGD:1345262 6480464 Methyl Methanesulfonate results in decreased expression of CYP51A1 mRNA CTD PMID:23649840 miconazole decreases activity ISO RGD:1345262 6480464 Miconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 miconazole increases expression ISO RGD:70832 6480464 Miconazole results in increased expression of CYP51 mRNA CTD PMID:27462272 , PMID:29337257 miconazole decreases response to substance ISO RGD:1345262 6480464 CYP51A1 gene results in decreased susceptibility to Miconazole CTD PMID:18694951 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CYP51 mRNA CTD PMID:22087261 N(6)-butyryl-cAMP multiple interactions ISO RGD:70832 6480464 [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA more ... CTD PMID:18467523 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP51 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:70832 6480464 Diethylnitrosamine results in increased expression of CYP51 mRNA CTD PMID:24535843 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CYP51 mRNA CTD PMID:19638242 obeticholic acid decreases expression ISO RGD:1345262 6480464 obeticholic acid results in decreased expression of CYP51A1 mRNA CTD PMID:27939613 ozone increases expression ISO RGD:70832 6480464 Ozone results in increased expression of CYP51 mRNA CTD PMID:12763052 paracetamol affects expression ISO RGD:70832 6480464 Acetaminophen affects the expression of CYP51 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:70832 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of CYP51 mRNA] CTD PMID:29246445 paracetamol increases expression ISO RGD:70832 6480464 Acetaminophen results in increased expression of CYP51 mRNA CTD PMID:29246445 paracetamol decreases expression ISO RGD:1345262 6480464 Acetaminophen results in decreased expression of CYP51A1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP51 mRNA CTD PMID:18246545 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP51 mRNA CTD PMID:18246545 penconazole decreases activity ISO RGD:1345262 6480464 penconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 perfluorooctane-1-sulfonic acid affects expression ISO RGD:70832 6480464 perfluorooctane sulfonic acid affects the expression of CYP51 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:70832 6480464 perfluorooctane sulfonic acid results in increased expression of CYP51 mRNA CTD PMID:20936131 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CYP51 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO RGD:70832 6480464 perfluorooctanoic acid results in decreased expression of CYP51A1 mRNA CTD PMID:30508572 perfluorooctanoic acid decreases expression ISO RGD:1345262 6480464 perfluorooctanoic acid results in decreased expression of CYP51A1 protein CTD PMID:26879310 perfluorooctanoic acid increases expression ISO RGD:1345262 6480464 perfluorooctanoic acid results in increased expression of CYP51A1 mRNA CTD PMID:23978341 , PMID:25868421 perfluorooctanoic acid increases expression ISO RGD:70832 6480464 perfluorooctanoic acid results in increased expression of CYP51A1 mRNA CTD PMID:17681415 perfluorooctanoic acid affects expression ISO RGD:70832 6480464 perfluorooctanoic acid affects the expression of CYP51 mRNA CTD PMID:19429403 phenobarbital affects expression ISO RGD:70832 6480464 Phenobarbital affects the expression of CYP51 mRNA CTD PMID:19136022 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP51 mRNA CTD PMID:19162173 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of CYP51 mRNA CTD PMID:18158353 phenylpropanolamine increases expression ISO RGD:1345262 6480464 Phenylpropanolamine results in increased expression of CYP51A1 mRNA CTD PMID:27756839 phosgene affects expression ISO RGD:70832 6480464 Phosgene affects the expression of CYP51 mRNA CTD PMID:16300373 phytosterols multiple interactions ISO RGD:70832 6480464 APOE gene mutant form affects the reaction [Phytosterols results in increased expression of CYP51 mRNA] CTD PMID:18155511 pirinixic acid affects expression ISO RGD:70832 6480464 pirinixic acid affects the expression of CYP51 mRNA CTD PMID:19136022 pirinixic acid increases expression ISO RGD:70832 6480464 pirinixic acid results in increased expression of CYP51 mRNA, pirinixic acid results in increased expression of CYP51A1 mRNA CTD PMID:17950772 more ... pirinixic acid multiple interactions ISO RGD:70832 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP51 mRNA more ... CTD PMID:17950772 more ... pirinixic acid decreases expression ISO RGD:70832 6480464 pirinixic acid results in decreased expression of CYP51 mRNA CTD PMID:18445702 potassium dichromate increases expression ISO RGD:1345262 6480464 Potassium Dichromate results in increased expression of CYP51A1 protein CTD PMID:23718831 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of CYP51 mRNA CTD PMID:27225895 pravastatin increases expression ISO RGD:70832 6480464 Pravastatin results in increased expression of CYP51 mRNA CTD PMID:27225895 prochloraz decreases activity ISO RGD:1345262 6480464 prochloraz results in decreased activity of CYP51A1 protein CTD PMID:16989930 progesterone increases expression ISO RGD:1345262 6480464 Progesterone results in increased expression of CYP51A1 mRNA CTD PMID:18070364 propiconazole increases expression ISO RGD:70832 6480464 propiconazole results in increased expression of CYP51 mRNA CTD PMID:16730040 more ... propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP51 mRNA CTD PMID:28970091 propiconazole decreases activity ISO RGD:1345262 6480464 propiconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 prothioconazole increases expression ISO RGD:70832 6480464 prothioconazole results in increased expression of CYP51 mRNA CTD PMID:29337257 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of CYP51 mRNA CTD PMID:22431067 quercetin decreases expression ISO RGD:70832 6480464 Quercetin results in decreased expression of CYP51A1 mRNA CTD PMID:16455785 quercetin decreases expression ISO RGD:1345262 6480464 Quercetin results in decreased expression of CYP51A1 mRNA CTD PMID:21632981 quercetin 3-O-beta-D-glucofuranoside multiple interactions ISO RGD:1345262 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA CTD PMID:18032389 quercetin 3-O-beta-D-glucopyranoside multiple interactions ISO RGD:1345262 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA CTD PMID:18032389 quinolin-8-ol decreases expression ISO RGD:1345262 6480464 Oxyquinoline results in decreased expression of CYP51A1 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:1345262 6480464 Lactic Acid results in increased expression of CYP51A1 mRNA CTD PMID:30851411 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of CYP51 mRNA CTD PMID:18299717 resveratrol increases expression ISO RGD:70832 6480464 resveratrol results in increased expression of CYP51 protein CTD PMID:25505154 Ritodrine decreases expression ISO RGD:70832 6480464 Ritodrine results in decreased expression of CYP51 mRNA CTD PMID:23370008 ritonavir increases expression EXP 6480464 Ritonavir results in increased expression of CYP51 mRNA CTD PMID:17719200 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CYP51 mRNA CTD PMID:28374803 silicon dioxide increases expression ISO RGD:70832 6480464 Silicon Dioxide results in increased expression of CYP51 mRNA CTD PMID:29203145 silver atom decreases expression ISO RGD:70832 6480464 Silver results in decreased expression of CYP51 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:70832 6480464 Silver results in decreased expression of CYP51 mRNA CTD PMID:27131904 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of CYP51 mRNA CTD PMID:25055962 sodium dodecyl sulfate decreases expression EXP 6480464 Sodium Dodecyl Sulfate results in decreased expression of CYP51 mRNA CTD PMID:12815608 sodium fluoride increases expression ISO RGD:70832 6480464 Sodium Fluoride results in increased expression of CYP51A1 protein CTD PMID:28918527 succimer multiple interactions ISO RGD:70832 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYP51 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP51 mRNA CTD PMID:21641980 , PMID:26378955 sunitinib increases expression ISO RGD:1345262 6480464 Sunitinib results in increased expression of CYP51A1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:70832 6480464 Tamoxifen affects the expression of CYP51 mRNA CTD PMID:20937368 tebuconazole decreases activity ISO RGD:1345262 6480464 tebuconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 tebuconazole increases expression ISO RGD:70832 6480464 tebuconazole results in increased expression of CYP51 mRNA CTD PMID:29337257 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CYP51 mRNA CTD PMID:15963342 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP51 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:70832 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP51 mRNA CTD PMID:30517762 tetracycline increases expression ISO RGD:70832 6480464 Tetracycline results in increased expression of CYP51 mRNA CTD PMID:16917069 thioacetamide increases methylation EXP 6480464 Thioacetamide results in increased methylation of CYP51 promoter CTD PMID:27914986 titanium dioxide increases expression ISO RGD:70832 6480464 titanium dioxide results in increased expression of CYP51 mRNA CTD PMID:23409001 tolcapone increases expression EXP 6480464 tolcapone results in increased expression of CYP51 mRNA CTD PMID:24136188 toluene affects expression EXP 6480464 Toluene affects the expression of CYP51 mRNA CTD PMID:18653662 triadimefon increases expression ISO RGD:70832 6480464 triadimefon results in increased expression of CYP51 mRNA CTD PMID:17178688 more ... triadimefon decreases activity ISO RGD:1345262 6480464 triadimefon results in decreased activity of CYP51A1 protein CTD PMID:16989930 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP51 mRNA CTD PMID:17178689 trimellitic anhydride increases expression ISO RGD:70832 6480464 trimellitic anhydride results in increased expression of CYP51 mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of CYP51 mRNA CTD PMID:30589522 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CYP51 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:70832 6480464 Valproic Acid affects the expression of CYP51 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid decreases expression ISO RGD:1345262 6480464 Valproic Acid results in decreased expression of CYP51A1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:1345262 6480464 Valproic Acid affects the expression of CYP51A1 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:1345262 6480464 Valproic Acid results in decreased methylation of CYP51A1 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:70832 6480464 Valproic Acid results in decreased expression of CYP51 mRNA CTD PMID:22045034 vancomycin increases expression ISO RGD:70832 6480464 Vancomycin results in increased expression of CYP51 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CYP51 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP51 mRNA CTD PMID:22570695 , PMID:23034163 voriconazole decreases response to substance ISO RGD:1345262 6480464 CYP51A1 gene results in decreased susceptibility to Voriconazole CTD PMID:18694951 voriconazole multiple interactions ISO RGD:1345262 6480464 CYP51A1 gene inhibits the reaction [Voriconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 zaragozic acid A increases expression ISO RGD:70832 6480464 squalestatin 1 results in increased expression of CYP51 mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CYP51 mRNA CTD PMID:27225895 zearalenone increases expression ISO RGD:70832 6480464 Zearalenone results in increased expression of CYP51 protein CTD PMID:25058043 zoledronic acid increases expression ISO RGD:1345262 6480464 zoledronic acid results in increased expression of CYP51A1 mRNA CTD PMID:24714768
Gene-Chemical Interaction Annotations
